NEGX

COM:NEXGENRX

NexgenRx

Stock

USD

Last Close

0.20

18/11 20:00

Market Cap

13.48M

Beta: -

Volume Today

2.50K

Avg: -

Overview Analysis Metrics Financials Filings API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
net income	-160.35K -	1.66M 1,135.67%	3.18M 91.28%	-16.52K 100.52%	-250.47K 1,415.71%
depreciation and amortization	642.18K -	735.47K 14.53%	1.06M 43.50%	1.04M 1.76%	986.54K 4.85%
deferred income tax	-63.70K -	-235.02K 268.95%	-1.60M 580.45%	129.51K 108.10%	8.35K 93.55%
stock based compensation	171.00K -	79.60K 53.45%	103.58K 30.13%	62.10K 40.04%	35.82K 42.32%
change in working capital	-1.80M -	-3.03M 67.99%	-320.67K 89.41%	1.29M 502.90%	-3.51M 371.47%
accounts receivables	214.57K -	6.70K 96.88%	-98.23K 1,566.76%	50.79K 151.70%	-352.23K 793.52%
inventory	1 -	-1.02 201.73%	0.00 100.00%	-0.00 500%	-1 429,496,729,500%
accounts payables	51.48K -	-221.06K 529.46%	423.73K 291.68%	-363.06K 185.68%	196.46K 154.11%
other working capital	-2.07M -	-2.81M 36.03%	-646.17K 77.04%	1.60M 348.27%	-3.35M 308.92%
other non cash items	12.02K -	66.82K 456.02%	-49.01K 173.34%	3.48K 107.11%	10.60K 204.28%
net cash provided by operating activities	-1.20M -	-721.48K 39.98%	2.37M 428.03%	2.51M 5.94%	-2.72M 208.34%
investments in property plant and equipment	-737.85K -	-845.80K 14.63%	-1.08M 28.02%	-373.73K 65.49%	-187.42K 49.85%
acquisitions net
purchases of investments
sales maturities of investments
other investing activites
net cash used for investing activites	-737.85K -	-845.80K 14.63%	-1.08M 28.02%	-373.73K 65.49%	-187.42K 49.85%
debt repayment	-82.90K -	-853.38K 929.42%	-399.68K 53.16%	-208.22K 47.90%	-79.23K 61.95%
common stock issued		78.49K -			47.16K -
common stock repurchased		0.56 -
dividends paid		-50.65K -	-103.15K 103.66%	-664.93K 544.63%	-680.81K 2.39%
other financing activites	-222.05K -	-195.29K 12.05%	-240.16K 22.98%	54.62K 122.74%
net cash used provided by financing activities	-304.95K -	-1.02M 234.75%	-743.00K 27.22%	-818.53K 10.17%	-693.43K 15.28%
effect of forex changes on cash	-1.93 -	-0.61 68.36%	-0.43 28.87%	-0.82 89.36%	7.65M 930,118,261.84%
net change in cash	2.23M -	3.21M 44.17%	1.96M 39.11%	-3.19M 263.34%	4.05M 226.89%
cash at beginning of period	8.57M -	10.79M 26.01%	14.01M 29.76%	15.96M 13.96%	12.77M 20.01%
cash at end of period	10.79M -	14.01M 29.76%	15.96M 13.96%	12.77M 20.01%	16.82M 31.75%
operating cash flow	-1.20M -	-721.48K 39.98%	2.37M 428.03%	2.51M 5.94%	-2.72M 208.34%
capital expenditure	-737.85K -	-845.80K 14.63%	-1.08M 28.02%	-373.73K 65.49%	-187.42K 49.85%
free cash flow	-1.94M -	-1.57M 19.20%	1.28M 181.92%	2.13M 66.19%	-2.90M 236.10%

All numbers in USD (except ratios and percentages)